Development and internal validation of a predictive model of overall and progression-free survival in eribulin-treated patients with breast cancer based on baseline peripheral blood parameters. - Natori K; Igeta M; Morimoto T; Nagahashi M; Akashi-Tanaka S; Daimon T; Miyoshi Y (Breast cancer (Tokyo, Japan), 2025)